Federal Register of Legislation - Australian Government

Primary content

PB 83 of 2021 Determinations/Health as made
This determination amends the National Health (Price and Special Patient Contribution) Determination 2021 by reflecting the price decrease to one brand of one pharmaceutical item due to a statutory price reduction. In addition, it also reflects the introduction of brand premiums and increases in existing brand premiums to multiple pharmaceutical items.
Administered by: Health
Registered 31 Jul 2021
Tabling HistoryDate
Tabled HR03-Aug-2021
Tabled Senate03-Aug-2021
Date of repeal 19 Oct 2021
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Table of contents.

Commonwealth Coat of Arms of Australia

 

PB 83 of 2021

 

National Health (Price and Special Patient Contribution) Amendment Determination 2021 (No. 5)

I, Nikolai Tsyganov, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care, make the following Determination.

Dated               27 July 2021               

NIKOLAI TSYGANOV

Acting Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 

 


Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments                                                                                           2

National Health (Price and Special Patient Contribution) Determination 2021 (PB 35 of 2021) 2

 

 


1  Name

                   This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2021 (No. 5).

                   This instrument may also be cited as PB 83 of 2021.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 August 2021.

 

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under section 85B of the National Health Act 1953.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.


Schedule 1Amendments

National Health (Price and Special Patient Contribution) Determination 2021 (PB 35 of 2021)

1  Schedule 1, entry for Amoxicillin

Omit

Amoxicillin

Capsule 250 mg (as trihydrate)

Oral

Amoxil

20

1.37

4.61

 

Capsule 500 mg (as trihydrate)

Oral

Amoxil

20

1.63

5.12

 

Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL

Oral

Amoxil

1

1.28

4.50

 

Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL

Oral

Amoxil Forte

1

1.59

4.90

 

Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL

Oral

Amoxil

1

5.88

6.37

 

Tablet 1 g (as trihydrate)

Oral

Maxamox

14

1.47

2.47

Substitute

Amoxicillin

Capsule 250 mg (as trihydrate)

Oral

Amoxil

20

1.37

4.61

 

Capsule 500 mg (as trihydrate)

Oral

Amoxil

20

1.63

5.12

 

Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL

Oral

Amoxil

1

1.28

4.50

 

Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL

Oral

Amoxil Forte

APO-Amoxycillin

1

1

1.59

1.59

 

4.90

2.29

 

Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL

Oral

Amoxil

1

5.88

6.37

 

Tablet 1 g (as trihydrate)

Oral

Maxamox

14

1.47

2.47

2  Schedule 1, after entry for Amoxicillin with Clavulanic Acid in the form Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)

Insert

Anastrozole

Tablet 1 mg

Oral

Arimidex

30

11.43

16.08

3  Schedule 1, after entry for Atenolol in the form Tablet 50 mg

Insert

Atomoxetine

Capsule 10 mg (as hydrochloride)

Oral

Strattera

28

36.16

38.49

 

Capsule 18 mg (as hydrochloride)

Oral

Strattera

28

36.16

38.49

 

Capsule 25 mg (as hydrochloride)

Oral

Strattera

28

36.16

38.49

 

Capsule 40 mg (as hydrochloride)

Oral

Strattera

28

36.16

38.49

 

Capsule 60 mg (as hydrochloride)

Oral

Strattera

28

36.16

38.49

 

Capsule 80 mg (as hydrochloride)

Oral

Strattera

28

47.01

51.66

 

Capsule 100 mg (as hydrochloride)

Oral

Strattera

28

47.01

51.66

 

4  Schedule 1, entry for Cefalexin

Omit

Cefalexin

Capsule 250 mg (as monohydrate)

Oral

Keflex

20

1.59

5.09

 

Capsule 500 mg (as monohydrate)

Oral

Keflex

20

1.73

6.82

 

Granules for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL

Oral

Keflex

1

1.82

5.68

 

Granules for oral suspension 250 mg (as monohydrate) per 5 mL, 100 mL

Oral

Keflex

1

2.10

7.39

Substitute

Cefalexin

Capsule 250 mg (as monohydrate)

Oral

APO-Cephalexin

Keflex

20

20

1.59

1.59

2.29

5.09

 

 

 

 

 

 

 

 

Capsule 500 mg (as monohydrate)

Oral

APO-Cephalexin

Keflex

20

20

1.73

1.73

2.43

6.82

 

 

 

 

 

 

 

 

Granules for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL

Oral

Keflex

1

1.82

5.68

 

Granules for oral suspension 250 mg (as monohydrate) per 5 mL, 100 mL

Oral

Keflex

1

2.10

7.39

5  Schedule 1, entry for Colchicine

(a)   omit from the column headed “Determined Price”:                        3.70        substitute:             2.78

(b)   omit from the column headed “Claimed Price”:                              6.40        substitute:             4.80

6  Schedule 1, entry for Duloxetine in the form Capsule 30 mg (as hydrochloride)

omit from the column headed “Claimed Price”:                       11.30      substitute:                15.95

7  Schedule 1, entry for Duloxetine in the form Capsule 60 mg (as hydrochloride)

omit from the column headed “Claimed Price”:                       12.95      substitute:                17.60

8  Schedule 1, entry for Esomeprazole in the form Tablet (enteric coated) 20 mg (as magnesium  trihydrate)

omit from the column headed “Claimed Price”:                       9.20        substitute:                10.52

9  Schedule 1, entry for Esomeprazole in the form Tablet (enteric coated) 40 mg (as magnesium  trihydrate)

omit from the column headed “Claimed Price”:                       13.30      substitute:                14.62

10  Schedule 1, entry for Furosemide

Omit

Furosemide

Tablet 20 mg

Oral

Lasix‑M

50

0.78

1.90

 

Tablet 40 mg

Oral

Lasix

100

1.56

3.79

Substitute

Furosemide

Tablet 20 mg

Oral

Lasix‑M

Frusemix-M

50

100

0.78

1.90

2.55

 

Tablet 40 mg

Oral

Lasix

100

1.56

3.79

11  Schedule 1, after entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 20 mg

Insert

Letrozole

Tablet 2.5 mg

Oral

Femara 2.5 mg

30

18.41

23.06

12  Schedule 1, after entry for Meloxicam in the form Tablet 15 mg

Insert

Mercaptopurine

Tablet containing mercaptopurine monohydrate 50 mg

Oral

Purinethol

25

40.15

42.01

13  Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 50 [Brand: Betaloc]

omit from the column headed “Claimed Price”:                       9.66        substitute:                11.52

14  Schedule 1, entry for Nizatidine in the form Capsule 150 mg

omit from the column headed “Claimed Price”:                       15.86      substitute:                16.77

15  Schedule 1, entry for Nizatidine in the form Capsule 300 mg

omit from the column headed “Claimed Price”:                       15.86      substitute:                16.77

16  Schedule 1, after entry for Norethisterone with Ethinylestradiol in the form Pack containing 21 tablets 1 mg‑35 micrograms and 7 inert tablets

Insert

Nortriptyline

Tablet 10 mg (as hydrochloride)

Oral

Allegron

50

3.55

4.05

 

Tablet 25 mg (as hydrochloride)

Oral

Allegron

50

4.46

5.46

17  Schedule 1, entry for Olanzapine in the form Tablet 2.5 mg

omit from the column headed “Claimed Price”:                       5.37        substitute:                10.03

18  Schedule 1, entry for Olanzapine in the form Tablet 5 mg

omit from the column headed “Claimed Price”:                       7.89        substitute:                12.54

19  Schedule 1, entry for Olanzapine in the form Tablet 7.5 mg

omit from the column headed “Claimed Price”:                       10.52      substitute:                15.17

20  Schedule 1, entry for Olanzapine in the form Tablet 10 mg

omit from the column headed “Claimed Price”:                       13.09      substitute:                17.74

21  Schedule 1, entry for Olanzapine in the form Wafer 5 mg

omit from the column headed “Claimed Price”:                       7.89        substitute:                12.54

22  Schedule 1, entry for Olanzapine in the form Wafer 10 mg

omit from the column headed “Claimed Price”:                       13.09      substitute:                17.74

23  Schedule 1, entry for Olanzapine in the form Wafer 15 mg

omit from the column headed “Claimed Price”:                       18.24      substitute:                22.89

24  Schedule 1, entry for Olanzapine in the form Wafer 20 mg

omit from the column headed “Claimed Price”:                       23.39      substitute:                28.04

25  Schedule 1, after entry for Rabeprazole in the form Tablet containing rabeprazole sodium 20 mg (enteric coated)

Insert

Raloxifene

Tablet containing raloxifene hydrochloride 60 mg

Oral

Evista

28

19.12

23.77

26  Schedule 1, entry for Spironolactone in the form Tablet 25 mg

omit from the column headed “Claimed Price”:                       8.73        substitute:                10.61

27  Schedule 1, entry for Spironolactone in the form Tablet 100 mg

omit from the column headed “Claimed Price”:                       19.00      substitute:                20.75

28  Schedule 1, after entry for Sumatriptan in the form Tablet (fast disintegrating) 50 mg (as succinate) [Pricing quantity/pack quantity 4]

Insert

Tamoxifen

Tablet 20 mg (as citrate)

Oral

Nolvadex-D

30

7.22

10.94

29  Schedule 1, entry for Zolmitriptan in the form Tablet 2.5 mg

omit from the column headed “Claimed Price”:                       6.81        substitute:                7.62